Company: CERO
Filing Date: 2025-11-28
Form Type: DEF 14A
Source: 0001213900-25-115783
Chunk: 94

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-28
Form: DEF 14A
Chunk 94
---
            | % |

____________ *Represents beneficial ownership of less than 1% of our outstanding Common Stock. (1)Unless otherwise noted, the business address of each of the following individuals is 210 Haskins Way, Suite 230, South San Francisco, CA 94080. (2)Consists of (i) 2,898shares of Common Stock, (ii) 3shares of Common Stock issuable upon the exercise of Warrants exercisable within 60 days of November 14, 2025, (iii) 18,082 shares of Common Stock issuable pursuant to stock options exercisable within 60 days of November 14, 2025, and (iv) 2 shares of Common Stock held by his spouse, Sara Fried. (3)Consists of 2,792shares of Common Stock, issuable pursuant to stock options exercisable within 60 days of November 14, 2025.

52 (4)Consists of 2,714shares of Common Stock issuable pursuant to stock options exercisable within 60 days of November 14, 2025. (5)Consists of (i) 63shares of Common Stock, (ii) 24,528shares of Common Stock, held by the Atwood -EdminsterTrust dtd 4 -2-2000(the “Trust”), of which Mr. Atwood and Lynne H. Edminster serve as trustees (iii) 3,417shares of Common Stock, issuable pursuant to stock options exercisable within 60 days of November 14, 2025 and (iv) shares underlying 10,787 Pre -FundedWarrants held by Mr. Atwood and GVN, LLC, which is the maximum number of such Pre -FundedWarrants held thereby that may be exercised without exceeding the beneficial ownership limitations set forth therein. Excludes warrants and/or pre -fundedwarrants held by Mr. Atwood and GVN, LLC (of which Mr. Atwood and Lynne H. Edminster serve as managers, and the sole member is the Trust) that are in excess of the applicable beneficial ownership limitations. (6)Consists of 2,388shares of Common Stock issuable pursuant to stock options exercisable within 60 days of November 14, 2025. (7)Consists of (i) 3shares of Common Stock held by Kathleen LaPorte, (ii) 483shares of Common Stock,